Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?

    Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66

  2. Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities

    Clinical and Translational Radiation Oncology, Vol. 45

2022

  1. Bone health and therapeutic agents in advanced prostate cancer

    Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1

2019

  1. Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy

    Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 607-614